Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Atomo Diagnostics Ltd. ( (AU:AT1) ) has issued an announcement.
Atomo Diagnostics Limited announced the resignation of Paul Kasian from its board of directors, effective May 2, 2025. This change in leadership may influence the company’s strategic direction and stakeholder relations, as Kasian held significant shares through Yongala Investments Pty Ltd, indicating his substantial involvement in the company’s operations.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Limited operates in the medical diagnostics industry, focusing on the development and commercialization of rapid diagnostic test devices. The company’s primary products include innovative testing solutions that aim to deliver accurate and timely health information, catering to both healthcare professionals and consumers.
Average Trading Volume: 458,408
Technical Sentiment Signal: Buy
Current Market Cap: A$12.14M
Learn more about AT1 stock on TipRanks’ Stock Analysis page.